Vor Biopharma Inc. (VOR)

Vor Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	33.77	60.12	122.21	50.1	8.03
Short-Term Investments	105.82	172.54	87.67	0	0
Cash & Cash Equivalents	139.59	232.66	209.88	50.1	8.03
Cash Growth	-40.00%	10.85%	318.94%	524.27%	763.83%
Other Current Assets	1.22	4.29	4.52	-0.99	-0.49
Total Current Assets	140.8	236.95	214.4	49.11	7.54
Property, Plant & Equipment	50.1	57.08	22.52	21.85	0.73
Other Long-Term Assets	7.23	5.34	5.67	4.96	1.56
Total Long-Term Assets	57.32	62.42	28.19	26.8	2.29
Total Assets	198.13	299.37	242.59	75.91	9.83
Accounts Payable	0.82	1.77	1.55	2.36	0.69
Current Debt	3.83	3.27	1.84	0.86	0
Other Current Liabilities	10.93	8.08	6.77	6.98	1.49
Total Current Liabilities	15.57	13.12	10.15	10.21	2.19
Long-Term Debt	31.83	35.64	16.17	17.43	0
Total Long-Term Liabilities	31.83	35.64	16.17	17.43	0
Total Liabilities	47.4	48.76	26.33	27.64	2.19
Total Debt	35.66	38.91	18.01	18.29	0
Debt Growth	-8.36%	116.02%	-1.53%	-	-
Retained Earnings	-340.08	-222.22	-130.12	-61.22	-17.89
Comprehensive Income	-0.08	-0.77	0	0	0
Shareholders' Equity	150.72	250.61	216.26	-59.07	-17.43
Net Cash / Debt	103.93	193.75	191.87	31.81	8.03
Net Cash / Debt Growth	-46.36%	0.98%	503.27%	296.32%	-
Net Cash Per Share	1.55	4.90	5.74	148.86	5.13
Working Capital	125.23	223.83	204.25	38.9	5.35
Book Value Per Share	2.24	6.34	6.47	-276.45	-11.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).